News

Article

Freudenberg Medical Completes Extractables Testing for Biopharma Tubing

The company worked with Eurofins Lancaster Laboratories to conduct independent extractables testing that involved eight solvents tested over a 21-day exposure time frame.

Freudenberg Medical, a contract manufacturer of medical device components and pharmaceutical tubing, announced it has completed testing on its PharmaFocus Premium silicone tubing used in biopharma fluid processing and single-use applications.

The company worked with Eurofins Lancaster Laboratories to conduct independent extractables testing that involved eight solvents tested over a 21-day exposure time frame, a May 18, 2020 company press release said. The tubing also underwent added physical, chemical, and biological tests.

“We understand that identifying extractable and leachable substances is extremely important for our biopharma customers,” said Jeff Mohror, vice-president and general manager of Freudenberg Medical Carpinteria, in the press release. “When specifying tubing into a process, this data will save customers valuable time and cost when bringing a new process into production.”

Source: Freudenberg Medical

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content